These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 19540083

  • 1. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
    Yuan Z, Ye XD, Dong S, Xu LC, Xu XY, Liu SY, Xiao XS.
    Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
    [Abstract] [Full Text] [Related]

  • 2. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z, Ye XD, Dong S, Xu LC, Sun ZC, Xiao XS.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H, Harman M, Cinar C, Bozkaya H, Parildar M, Elmas N.
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [Abstract] [Full Text] [Related]

  • 4. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
    Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS.
    Eur J Radiol; 2012 Mar; 81(3):472-7. PubMed ID: 21296517
    [Abstract] [Full Text] [Related]

  • 5. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Yuan Z, Ye XD, Dong S, Xu LC, Xiao XS.
    J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
    [Abstract] [Full Text] [Related]

  • 10. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.
    Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, Husband JE.
    AJR Am J Roentgenol; 2007 Apr; 188(4):1001-8. PubMed ID: 17377036
    [Abstract] [Full Text] [Related]

  • 11. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.
    Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B.
    AJR Am J Roentgenol; 2009 Oct; 193(4):1044-52. PubMed ID: 19770328
    [Abstract] [Full Text] [Related]

  • 12. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS, Kim JH, Chung JJ, Kim KW.
    J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
    [Abstract] [Full Text] [Related]

  • 13. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
    Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B.
    Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H, Wang XY, Jiang XX, Ye ZX.
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N, Camacho JC, Xing M, Edalat F, Mittal PK, Kim HS.
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.